Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01619553

Genetic Analysis of Keloids

Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Connecticut Health Center (UCHC)

Farmington, Connecticut, 06030-3705, United States

Location status: Recruiting

About this study

Keloids are scars that keep growing beyond the border of the original wound. They typically persist for several years, expand for an extensive period of time and are sometimes called benign tumors. Keloids often have a lumpy surface and are often tender, itchy or inflamed around the growing border.

Keloids in most keloid patients do not run in the family. In the inheritable form of keloids it is possible that there is one major gene mutation that puts family members at risk for developing keloids. There may be other variations in the DNA (DNA makes up the chromosomes) that determine whether keloids become large and aggressive or stay small and without many symptoms.

For this study we will:

  • Send out study participation kits and consent by phone
  • Collect a saliva sample from eligible individuals
  • Obtain information regarding the keloids
  • Document keloids with photos
  • If keloid patients undergo keloid surgery we ask to obtain some scar tissue that would otherwise be discarded
  • Isolate DNA from the saliva sample
  • Perform genetic analyses of the DNA with the most up-to-date methods available to identify genetic variations
  • Study in the laboratory why the genetic variations cause keloids

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • keloids;
  • unaffected individuals only if part of a participating keloid family

Exclusion criteria

  • no keloids;
  • unaffected individuals only as part of a participating keloid family

Treatment and study plan

Primary outcomes

  1. Identification of genetic elements

    Time frame: at time of identification

    The goal is to identify relevant genes or genetic elements that cause the disease or contribute to the disease progression and severity.

Study contacts

Contact information is provided by the study sponsor or research team.

Ernst Reichenberger, PhD

CONTACT

[email protected]

866-512-9897

Sponsors and collaborators

Lead sponsor

UConn Health

Other

Registry information

Official study title

Identification of Genetic Variants That Contribute to Keloid Formation in Families and Isolated Cases.

Important dates

Study start
2009
Primary completion
2030
Study completion
2030
First posted
Jun 14, 2012
Registry last updated
Apr 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.